Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

Cancer treatment in the age of COVID-19 and the current worldwide impact

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 24.03.20
Views: 2240

Prof Richard Sullivan - Kings College London, UK

Prof Richard Sullivan speaks to ecancer about the effect on cancer treatment in the age of COVID-19 and the current worldwide impact.

He explains that at the moment the data coming out is mostly epidemiological and that there just isn't enough data out there on cancer and COVID-19 patients to inform clinical judgements.

Prof Sullivan also discusses the effect of the spread of the virus in low-middle-income countries and believes that the low infection rates are down to the fact that these countries are unable to rigorously test their populations.

He also believes that the impact of the lockdowns on access to cancer treatments could be a major cause for concern.

Prof Sullivan asserts that any piece of information we have on the effect of COVID-19 on cancer patients is essential going forward.

Related videos

follow us

SIOG metastatic renal cell carcinoma

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation